Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174393 · ClinicalTrials.gov registry record · NA
Microneedling Plus the Universal Peel For Acne Scarring
A NA study, sponsored by Englewood Hospital and Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT02174393 is a NA study that has completed, run by Englewood Hospital and Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT02174393, a NA study, has completed, sponsored by Englewood Hospital and Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Acne is a prevalent disorder mostly witnessed in adolescents, but can be seen in adults. Early treatment is imperative to reduce acne scarring which can appear with atrophic lesions, and depending on the skin type, significant erythema (redness) or post-inflammatory hyperpigmentation. A multi-modality approach to treatment is necessary when dealing with the aforementioned types of lesions. Pharmacologic management is essential, but safe procedural therapies are also necessary specifically with darker skinned individuals. Percutaneous collagen induction therapy (PCIT) is a non-invasive treatment achieved by using a micro-needling device, which is safe and effective in causing "micro-wounds" into the dermis thereby initiating wound healing followed by collagen production. This is an ideal treatment for acne scarring, re-texturizing of the skin, and hyperpigmentation for all skin types . Currently there are very few studies evaluating the safety and efficacy of microneedling and chemical peels in skin types III-VI. The aim of this study is to evaluate the effects of the combination of microneedling and chemical peel for the treatment of acne scars in skin types III-VI.
Interventions
- PROCEDURE Microneedling
- DRUG Universal Peel
- DRUG Post-Microneedling Skin Care
- DRUG Post-Universal Peel Skin Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02174393
The ClinicalTrials.gov registry entry for NCT02174393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Englewood Hospital and Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Microneedling is the first listed.
NCT02174393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02174393 about?
NCT02174393 is a clinical study titled "Microneedling Plus the Universal Peel For Acne Scarring". Acne is a prevalent disorder mostly witnessed in adolescents, but can be seen in adults. Early treatment is imperative to reduce acne scarring which can appear with atrophic lesions, and depending on the skin type, significant erythema (redness) or post-inflammatory hyperpigmentation. A multi-modali...
What is the current status of trial NCT02174393?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2014-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02174393?
The interventions under investigation include: Microneedling (PROCEDURE), Universal Peel (DRUG), Post-Microneedling Skin Care (DRUG), Post-Universal Peel Skin Care (DRUG).
Who is sponsoring clinical trial NCT02174393?
This trial is sponsored by Englewood Hospital and Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.